000
| 02844nam 2200517zi 4500 |
---|
001 | 9.890940 |
---|
003 | CaOODSP |
---|
005 | 20221107172737 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 200827t20202020onc ob f000 0 eng d |
---|
020 | |a9780660359038 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH21-312/2020E-PDF |
---|
245 | 04|aThe Canadian cannabis survey 2020 : |bmethodological report / |cprepared for Health Canada. |
---|
264 | 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2020. |
---|
264 | 4|c©2020 |
---|
300 | |a1 online resource (106 pages) + |eexecutive summary + detailed tables |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Enquête canadienne sur le cannabis 2020 : rapport méthodologique. |
---|
500 | |aMethodological report and executive summary issued also in HTML format. |
---|
500 | |a"Supplier name: Advanis Inc." |
---|
500 | |a"June 2020." |
---|
500 | |a"Contract number: HT372-194392 001 CY." |
---|
500 | |a"Registration number: POR 114-19." |
---|
504 | |aIncludes bibliographical references. |
---|
520 | |a"The 2020 Canadian Cannabis Survey aimed to gather additional information to track changes in data collected from the 2017, 2018 and 2019 surveys, more specifically patterns of use, such as the quantities used; sources and pricing; and issues of public safety, such as impaired driving"--Page 2. |
---|
650 | 0|aCannabis|zCanada|xPublic opinion. |
---|
650 | 0|aMarijuana|zCanada|xPublic opinion. |
---|
650 | 0|aMarijuana abuse|zCanada|xPublic opinion. |
---|
650 | 0|aMarijuana|xTherapeutic use|zCanada|xPublic opinion. |
---|
650 | 0|aPublic opinion|zCanada. |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
710 | 2 |aAdvanis (Firm), |econsultant. |
---|
775 | 08|tEnquête canadienne sur le cannabis 2020 : |w(CaOODSP)9.890941 |
---|
794 | |tThe Canadian cannabis survey 2021 : |w(CaOODSP)9.902097 |
---|
795 | |tThe Canadian cannabis survey 2019 : |w9.875402 |
---|
856 | 40|qPDF|s1.44 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H21-312-2020-eng.pdf|z(methodological report) |
---|
856 | 40|qPDF|s112 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H21-312-2020-1-eng.pdf|z(executive summary) |
---|
856 | 40|qPDF|s5.44 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H21-312-2020-2-eng.pdf|z(detailed tables) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/114-19-e/CCS_methodological_report-eng.html|z(methodological report) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/114-19-e/summary/CCS_executive_summary-eng.html|z(executive summary) |
---|